MiR-454 Prompts Cell Proliferation of Human Colorectal Cancer Cells by Repressing CYLD Expression |
Liang, Hong-Liang
(Department of Gastroenterology, Shandong Provincial Hospital, Shandong University)
Hu, Ai-Ping (Department of Oncology, Liaocheng Tumor Hospital) Li, Sen-Lin (Department of Gastroenterology, Liaocheng People's Hospital) Xie, Jia-Ping (Department of Gastroenterology, Liaocheng People's Hospital) Ma, Qing-Zhu (Department of Gastroenterology, Liaocheng People's Hospital) Liu, Ji-Yong (Department of Gastroenterology, Shandong Provincial Hospital, Shandong University) |
1 | Alameda JP, Moreno-Maldonado R, Navarro M, et al (2010). An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene, 29, 6522-32. DOI |
2 | Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5. DOI |
3 | Andre T, Tuvignon N, Taieb J, et al (2010). Operable colon cancer: initial strategy. Rev Prat, 60, 1089-93. |
4 | Aschele C, Bergamo F, Lonardi S (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev, 35, 509-16. DOI |
5 | Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI |
6 | Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. DOI |
7 | Chen P, Wang BL, Pan BS, et al (2014). MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer Prev, 15, 9185-90. DOI |
8 | Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. DOI |
9 | Gao Y, Li BD, Liu YG (2013). Effect of miR27a on proliferation and invasion in colonic cancer cells. Asian Pac J Cancer Prev, 14, 4675-8. DOI |
10 | Iliopoulos D, Jaeger SA, Hirsch HA, et al (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell, 39, 493-506. DOI ScienceOn |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Kinoshita H, Okabe H, Beppu T, et al (2013). CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma. Mol Clin Oncol, 1, 309-14. |
13 | Knudsen KE, Diehl JA, Haiman CA, et al (2006). Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 1620-8. DOI ScienceOn |
14 | Massoumi R, Chmielarska K, Hennecke K, et al (2006). Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell, 125, 665-77. DOI |
15 | Miliani de Marval P, Lutfeali S, Jin JY, et al (2011). CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. Cancer Prev Res, 4, 851-9. DOI |
16 | Primrose JN (2010). Surgery for colorectal liver metastases. Br J Cancer, 102, 1313-8. DOI |
17 | Raman M, Ambalam P, Kondepudi KK, et al (2013). Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes, 4, 181-92. DOI |
18 | Ratschiller D, Heighway J, Gugger M, et al (2003). Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol, 21, 2085-93. DOI |
19 | Rico-Rosillo MG, Vega-Robledo GB, Oliva-Rico D (2014). The role and importance of the microRNAs in the diagnosis and development of diseases. Rev Med Inst Mex Seguro Soc, 52, 302-7. |
20 | Roy AL, Carruthers C, Gutjahr T, et al (1993). Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature, 365, 359-61. DOI |
21 | Sharma M, Sharma S, Arora M, et al (2013). Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909. Gene, 522, 60-4. DOI |
22 | Shi L, Wang Z, Sun G, et al (2014). miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med, 16, 517-28. DOI |
23 | Suppiah A, Hartley JE, Monson JR (2009). Advances in radiotherapy in operable rectal cancer. Dig Surg, 26, 187-99. DOI |
24 | Xia JT, Chen LZ, Jian WH, et al (2014). MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kappaB signaling. J Transl Med, 12, 33. DOI |
25 | Zhang L, Dong Y, Zhu N, et al (2014). microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer, 13, 124. DOI |
26 | Zhong Q, Wang T, Lu P, et al (2014). miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res, 92, 619-26. DOI ScienceOn |